Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
1&1 AG | 1U1 | Mar 31, 2025 | 15.18 | +0.93 |
AIXTRON SE | AIXA | Mar 31, 2025 | 10.14 | -4.07 |
ATOSS Software SE | AOF | Mar 31, 2025 | 125.00 | -2.04 |
Bechtle AG | BC8 | Mar 31, 2025 | 34.20 | -3.39 |
Cancom SE | COK | Mar 31, 2025 | 22.44 | -15.13 |
Carl Zeiss Meditec A G | AFX | Mar 31, 2025 | 60.60 | -7.76 |
Cdax-Gesamtindex (Perf) | CDAX | Mar 31, 2025 | 1 888.11 | -1.34 |
CompuGroup Medical SE & Co KgaA | COP | Mar 31, 2025 | 22.60 | -0.44 |
Dax (Performanceindex) | DAX | Mar 31, 2025 | 22 163.00 | -1.33 |
Deutsche Telekom AG | DTE | Mar 31, 2025 | 34.22 | +0.26 |
Eckert & Ziegler SE | EUZ | Mar 31, 2025 | 55.55 | -1.16 |
Elmos Semiconductor SE | ELG | Mar 31, 2025 | 58.20 | -3.48 |
Evotec SE | EVT | Mar 31, 2025 | 6.06 | +1.00 |
Formycon AG | FYB | Mar 31, 2025 | 22.90 | -3.58 |
Freenet AG | FNTN | Mar 31, 2025 | 35.24 | +0.40 |
Hensoldt AG | HAG | Mar 31, 2025 | 61.75 | -2.29 |
Infineon Technologies AG | IFX | Mar 31, 2025 | 30.40 | -2.36 |
IONOS GROUP SE NA O.N. | IOS | Mar 31, 2025 | 25.55 | -1.35 |
Jenoptik AG | JEN | Mar 31, 2025 | 19.09 | -3.24 |
Kontron AG. | KTN | Mar 31, 2025 | 22.14 | +0.36 |
Mdax (Performanceindex) | MDAX | Mar 31, 2025 | 27 393.00 | -1.65 |
Nagarro SE | NA9 | Mar 31, 2025 | 73.65 | -2.06 |
Nemetschek SE | NEM | Mar 31, 2025 | 106.80 | -3.17 |
Nordex SE | NDX1 | Mar 31, 2025 | 14.23 | -3.59 |
PNE AG | PNE3 | Mar 31, 2025 | 14.14 | +0.14 |
QIAGEN NV | QIA | Mar 31, 2025 | 36.67 | -0.34 |
Sap SE | SAP | Mar 31, 2025 | 244.40 | -0.95 |
Sartorius AG PRF PERPETUAL EUR | SRT3 | Mar 31, 2025 | 213.60 | -3.35 |
Sdax (Performance-Index) | SDXP | Mar 31, 2025 | 15 233.00 | -2.50 |
Siemens Healthineers AG | SHL | Mar 31, 2025 | 49.61 | -2.15 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.